复方红豆杉胶囊治疗晚期血小板降低非小细胞肺癌1例
发布时间：2019-06-20 04:31
【摘要】：正非小细胞肺癌(non-small-cell lung cancer,NSCLC)的治疗以手术为主,然而因患者就诊时多为中晚期,仅20%~30%的患者在确诊后有手术指征。以化疗、放疗和靶向治疗为主的个体化综合治疗是晚期NSCLC的主要治疗模式。但化疗的不良反应限制了其使用,特别是对于一些高龄及并发症较多的患者,由于一般情况差,使其不能耐受正规联合化疗甚至单药化疗。对于此类因为各种原因无法耐受化疗且表皮生长因子受体-酪氨酸
[Abstract]:The treatment of positive non-small cell lung cancer (non-small-cell lung cancer,NSCLC) is mainly surgery. However, only 20% of the patients have surgical indications after diagnosis because most of the patients are in the middle and late stages of treatment. Individualized comprehensive therapy based on chemotherapy, radiotherapy and targeted therapy is the main treatment mode of advanced NSCLC. However, the adverse reactions of chemotherapy limit its use, especially for some elderly patients with more complications, because of the poor general situation, they can not tolerate formal combined chemotherapy or even single drug chemotherapy. For these cases, chemotherapy is intolerable for a variety of reasons and epidermis growth factor receptor-Tyrosine is not tolerable for a variety of reasons.
【作者单位】： 第三军医大学大坪医院野战外科研究所肿瘤中心;
【分类号】：R273
[Abstract]:The treatment of positive non-small cell lung cancer (non-small-cell lung cancer,NSCLC) is mainly surgery. However, only 20% of the patients have surgical indications after diagnosis because most of the patients are in the middle and late stages of treatment. Individualized comprehensive therapy based on chemotherapy, radiotherapy and targeted therapy is the main treatment mode of advanced NSCLC. However, the adverse reactions of chemotherapy limit its use, especially for some elderly patients with more complications, because of the poor general situation, they can not tolerate formal combined chemotherapy or even single drug chemotherapy. For these cases, chemotherapy is intolerable for a variety of reasons and epidermis growth factor receptor-Tyrosine is not tolerable for a variety of reasons.
【作者单位】： 第三军医大学大坪医院野战外科研究所肿瘤中心;
【分类号】：R273
【相似文献】
相关期刊论文 前10条
1 仇玲飞;舒琦瑾;;复方红豆杉胶囊联合中药降低恶性肿瘤相关指标3例[J];江西中医学院学报;2012年06期
2 刘琳琳;胡志敏;;复方红豆杉胶囊配合肺积消1号方治疗老年晚期肺癌32例[J];实用中医内科杂志;2008年03期
3 薛忠;;复方红豆杉胶囊治疗中晚期恶性肿瘤42例[J];世界中医药;2010年05期
4 杨爱珍;王蕊;厉璐帆;刘向荣;马世平;;复方红豆杉胶囊对S_(180)肉瘤血管生成的抑制作用[J];药学与临床研究;2010年05期
5 贺兼斌;廖慧中;;复方红豆杉胶囊对老年Ⅲ、Ⅳ期非小细胞肺癌患者的治疗作用[J];临床医学;2012年11期
6 杨远游;程海民;穆晓峰;宁健;;复方红豆杉胶囊治疗高龄肺癌1例[J];第三军医大学学报;2014年01期
7 王海明;任芳;;复方红豆杉胶囊治疗老年中晚期肺癌24例临床观察[J];科学技术与工程;2014年06期
8 滕红丽;李s，
本文编号：2502931
本文链接：https://www.wllwen.com/zhongyixuelunwen/2502931.html
